血管质量倡议中复杂腹主动脉瘤腔内修复术后的III型内漏
基于血管质量倡议(VQI)2010年1月至2020年3月的回顾性队列,分析4070例复杂腹主动脉瘤腔内修复术(c-EVAR),其中2656例(65.2%)有合适随访数据。术中III型内漏发生率为4.1%(167例),随访中新发III型内漏发生率为0.04%(1例)。使用定制或医生修改装置的患者术中III型内漏比例更高(78.4% vs 49.2%,P < .001),但术中III型内漏与主动脉再干预或死亡率无统计学显著关联。
要点
- c-EVAR术中III型内漏发生率为4.1%,随访中新发III型内漏发生率为0.04%。
- 使用定制或医生修改装置的患者术中III型内漏比例更高(78.4% vs 49.2%,P < .001)。
- 术中III型内漏与主动脉再干预或死亡率无统计学显著关联,但事件数少、II类错误风险高。
核心结论
- c-EVAR中III型内漏相对不常见,主要在索引住院期间被发现。
- III型内漏的发生与更高的装置模块化和修改相关,提示随着装置技术更复杂,III型内漏可能持续存在并需要继续评估。
- 本研究中III型内漏与主动脉再干预或生存无统计学显著关系,但由于事件率低和II类错误可能性高,这些发现并非确定性结论。
- 鉴于装置疲劳和退化的理论风险,延长随访间隔的大队列持续评估和认真报告仍然至关重要。
研究设计与样本
- 回顾性队列综述,纳入血管质量倡议(VQI)中2010年1月至2020年3月因非破裂动脉瘤行择期c-EVAR的病例。
- VQI标准定义c-EVAR为肾上或肾旁腹主动脉瘤采用胸腹修复、开窗/分支修复、平行支架修复、定制装置和医生修改腔内移植物修复。
- 共识别4070例c-EVAR,其中2656例(65.2%)有合适随访数据。
- 索引内漏定义为索引住院期间发现的内漏;新发内漏定义为索引住院期间不存在、随访中发现的新内漏。
主要发现
- 队列中一半使用修改或定制移植物(n = 2055/4070;50.5%)。
- 分支用于3687例(90.5%),开窗和烟囱技术分别记录于13%(n = 533)和15.1%(n = 613)。
- 索引III型内漏发生率为4.1%(n = 167),随访中新发III型内漏发生率为0.04%(n = 1)。
- 索引III型内漏患者中使用定制或医生修改装置的比例为78.4%(n = 131/167),无索引III型内漏患者中为49.2%(n = 1924/3903)(P < .001)。
- 与无III型内漏者相比,索引III型内漏的存在与主动脉再干预增加或死亡率增加无统计学关联。
临床怎么用
- 原文结论未据此给出推荐。
局限性
- 原文指出这些发现并非确定性结论,原因是事件率低和II类错误可能性高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Type III endoleaks (T3ELs) following complex endovascular aneurysm repair (c-EVAR) for abdominal aortic aneurysm have been historically difficult to study due to their relative rarity. Previous studies within standard infrarenal EVAR have found an association between T3ELs and decreased survival. This study aims to evaluate the occurrence of T3ELs in a national multicenter cohort, identify potential procedural characteristics associated with T3EL development, and determine their impact on clinical outcomes in c-EVAR. METHODS: A retrospective cohort review was conducted of elective c-EVAR for nonruptured aneurysms within the Vascular Quality Initiative (VQI) between January 2010 and March 2020. The VQI standards define c-EVAR as suprarenal or pararenal abdominal aortic aneurysms repaired with any thoracoabdominal repairs, fenestrated/branched repairs, parallel stent repairs, custom manufactured devices, and physician-modified endografts. End points assessed were rates of T3ELs within c-EVAR, and impact of T3ELs on reintervention and survival. Index endoleaks were defined as endoleaks discovered during index hospitalization. Incident endoleaks were defined as new endoleaks, which were not present at index hospitalization, discovered at follow-up. RESULTS: A total of 4070 c-EVAR cases were identified between January 2010 and March 2020, of which 2656 (65.2%) had appropriate follow-up data. One-half of the cohort had a modified or custom graft (n = 2055/4070; 50.5%). Branches were employed in 3687 patients (90.5%), whereas fenestrations and chimney techniques were documented in 13% (n = 533) and 15.1% (n = 613), respectively. The rate of index T3ELs was 4.1% (n = 167), and the rate of incident T3ELs at follow-up was 0.04% (n = 1). Devices categorized as either custom or physician-modified were utilized more frequently in patients with index T3ELs (78.4%; n = 131/167) compared with patients without index T3ELs (49.2%; n = 1924/3903) (P < .001). Compared with those without T3ELs, the presence of index T3ELs was not statistically associated with increased aortic reinterventions or increased mortality. CONCLUSIONS: T3ELs in c-EVAR remain relatively uncommon and are identified predominately at index hospitalization. Development of T3EL was associated with higher device modularity and modification, which suggests that as device technologies continue to advance and become more intricate, the occurrence of T3ELs may persist and continue to require evaluation. In this study, the presence of T3ELs did not appear to have a statistically significant relationship with aortic reinterventions or survival; however, these findings are not definitive due to low event rate numbers and high potential for type II errors. Amid the theoretical risk of device fatigue and degeneration, continued evaluations of large cohorts at extended follow-up intervals and diligent reporting remain paramount.
引用
- Blakeslee-Carter J, Beck AW, Spangler EL, et al. Type III endoleaks in complex endovascular abdominal aortic aneurysm repair within the Vascular Quality Initiative. J Vasc Surg. 2021. PMID: 34740805. doi:10.1016/j.jvs.2021.10.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。